Austco Healthcare (AHC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
19 Aug, 2026Investment highlights
FY25 revenue reached $81.4m, up 40% YoY, with EBITDA at $13.0m, up 62% YoY, and a 16% EBITDA margin.
Operates in a global healthcare digitalisation market projected to grow at 25.7% CAGR to $1.9t by 2031.
Offices in 6 countries, installations in 50 countries, and 270 employees worldwide.
Only IP-native nurse call platform with integrated RTLS and workflow applications, expanding software revenue.
Debt-free with $14.5m cash and $53.8m in unfilled contract revenue, providing future earnings visibility.
Market opportunity and demand drivers
Ageing population (65+) expected to double to 1.5b by 2050, increasing care demand.
Staff shortages projected to exceed 100,000 by 2028, driving need for efficiency.
Patient experience and care delivery flexibility are key differentiators.
Healthcare digitalisation and compliance markets growing rapidly.
Solutions and technology
Comprehensive platform includes communication, workflow optimisation, and asset tracking.
End-to-end solutions provide audit trails, instant alerts, and efficiency improvements.
Integrated platform connects nurse call, medical devices, RTLS, and mobile apps, reducing alarm fatigue and improving outcomes.
Customisable for each facility, supporting unified communications and multi-language needs.
Built-in RTLS with custom staff roles and advanced workflow automation.
Latest events from Austco Healthcare
- Record revenue, profit, and recurring software growth, with strong cash and major contract wins.AHC
H2 2026 - Record revenue and profit growth driven by contracts, acquisitions, and software innovation.AHC
Investor presentation - Record revenue, profit, and software growth driven by acquisitions and innovation.AHC
Investor presentation - Record revenue and profit growth, with strong order backlog and positive growth outlook.AHC
H2 2024 - Record Q1 revenue growth and major contract wins drive strong outlook for continued expansion.AHC
Q1 2025 TU - First-half FY25 revenue and EBITDA are set to surge, boosted by acquisitions and organic growth.AHC
Q2 2025 TU - Record revenue and EBITDA growth, strong profit, and robust order book support future performance.AHC
H1 2025 - Revenue and EBITDA surged year-over-year, with strong cash flow and robust contracted revenue.AHC
Q4 2025 TU - Record revenue and EBITDA growth, strong cash, and robust orders position for continued expansion.AHC
H2 2025